CMPMedica ceased to publish two of its titles - Infections in Medicine and AIDS Reader - due to a continuing decline in print advertising sales.

Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff to improve dialogue between diabetics and their caregivers, and facilitate the integration of Accu-Check products into the lives of patients.

Sanofi-Aventis announced plans to restructure its R&D model, set to be completed by 2013.

The Supreme Court will not take on a New Hampshire data ban enacted in 2006, overturned 10 months later by a district court, and then reinstated by a federal appeals court last November.

AstraZeneca is rolling out an unbranded COPD education campaign featuring comedian and actor Robert Klein.

FDA took issue with a professional mailer and detachable card used at the recent ASCO conference, calling the reminder labeling inappropriate. The ad also overstated the efficacy of Velcade, according to the letter.

Kathleen Buto, vice president, health policy, for Johnson & Johnson told a congressional committee the pharmaceutical industry is concerned a public health plan could undermine a market-based system that provides incentives for long-term research

Drug and advertising industry advocates are sounding the alarm over congressional threats to tax drug advertising.

DazMedia hopes to leverage its interactive work with Bayer on Betaseron, an MS treatment, into other product and condition areas for a new website: Real World Health. The site is expected to launch during the third quarter, and may include condition areas such as Alzheimer's, diabetes and/or HIV.

PhRMA has committed to finding $80 billion in savings on drugs sold in the US over ten years, including selling drugs at half-price to seniors in the Medicare Part D "donut hole" coverage gap.